Zandu Realty Ltd Equity Stock share price today (on 22 March 2023).

We Provide Best stock tips for Zandu Realty Ltd Equity Stock. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Zandu Realty Ltd Equity Stock with today performance in nse market. Contact Us for Jackpot Stock tips.

Get Free Stock Tips for Zandu Realty Ltd Equity Stock

Live Chart of Zandu Realty Ltd

BSE: 506720 | NSE: ZANDUREALT | ISIN: INE719A01017
Market Cap: [Rs.Cr.] 121 | Face Value: [Rs.] 100
Industry: Construction

Zandu Pharmaceutical Works Ltd is an India-based pharmaceutical company. The company is a manufacturer of ayurvedic health promoting products, chemicals and cosmetics. Using approximately 200 medicinal plants and their extracts, Zandu produces a range of over 300 health promoting products. The products are manufactured at several plants across India. Their manufacturing plants are located at Mumbai and Dongari in Maharashtra, Vapi in Gujarat and Silvassa in Dadra & Nagar Haveli. The Company operates through two segments, namely Pharmaceuticals and Chemicals. Their products include ghritas, medical oils, churna, quath, tablets and pills. The company products are sold under the trade name 'ZANDU'. Some of their brands include Zandu Balm, Zandu Pancharishta, Trishun, Chyavanprash, and Zandu Kesari-Jivan. Zandu Pharmaceutical Works Ltd was incorporated in the year 1919 in Mumbai. The company went to public in the year 1920. In the year 1930, the company added allopathic medicines to their product line. In February 1989, Leopard Investments Pvt Ltd became the subsidiary of the company.
In the year 1995, the company set up a new manufacturing unit at Piparia in Dadra & Nagar Haveli. They also set up another unit at Medak in Hyderabad. In the year 1996, they entered into a joint venture with Gujarat Agro Industries Corporation for a vegetable plant-extraction project to manufacture glycyrrhiza extract. During the year 1998-99, the company set up a new manufacturing unit at Masat (Silvassa) to meet the increasing demand for their products. During the year 2003-04, the company won the first prize in the business summit/ exhibition organized by Central Bank of India. Also they bagged 2 first prizes, 1 third prize and 2 rolling tropies at Exhibition of Vegetables, Fruits and Flowers organized by BMC and Friends of Trees Authority. Leopard Investment Ltd ceased to be subsidiary of the company during the year. During the year 2004-05, the two products of the company namely Zandu Balm and Kesari Jivan were selected as Superbrands in India by Superbrands Organisation, London. In January 2004, the company received an award for 'Excellence in Brand Building'. During the year 2005-06, the company started the new Ayurvedic Professional Division named 'Bhishag'.
During the year 2006-07, the company acquired 44.20% of the share capital of Zandu Chemicals Ltd. As a result, the company holds 93.84% interest in Zandu Chemicals Ltd. Thus, Zandu Chemicals Ltd became the subsidiary of the company. During the year 2007-08, the company set up a State of the Art manufacturing unit at Uttarakhand to improve the operational efficiency of the company. In October 2008, Emami Ltd acquired 22.82% interest in the company. As a result, Emami Ltd holds 50.33% interest in the company and became the holding company. During the year 2008-09, the company sold their investments in Zandu Chemicals Ltd. Thus Zandu Chemicals Ltd ceased to be a subsidiary of the company. During the first quarter of the financial year 2009-10, the company commenced their commercial production in Uttarakhand Unit. In June 2009, the company and Emami Ltd announced the de-merger of the realty undertaking of Emani Ltd into a separate company, namely Slick Properties Pvt Ltd to be renamed as Emami Infrastructure

Histry & Events

1947 - 5,000 Right Preference shares issued at par in proportion
1:3.

1969 - 2,500 Bonus Right Equity shares issued at par in the prop.
1:6.

1971 - 2,500 Right Equity shares issued at par in the prop. 1:7.

1972 - 2,500 Right Equity shares issued at par in the prop. 1.8.

1974 - 2,500 Right Equity shares issued at par in the prop. 1.9.

1975 - 10,000 Bonus Equity shares issued in prop. 2:5.

1983 - The Company achieved commercial cultivation of glycirrhiza
roots
at Anand.

- 5,000-7 1/2% Pref. shares cancelled against the issue of bonds
as
29.9.1983.

1985 - 21,000 Bonus shares issued in prop. 3:5.

1993 - 28,000 Bonus shares issued in prop. 1:2 on 12th January,
1990.
Another 84,000 bonus shares issued in proportion 1:1 on
10.12.1991.

1994 - 1,68,000 bonus shares issued in prop. 1:1.

1995 - The Company has set up a new manufacturing unit at Piparia
(Dadra
& Nagar Haveli), another unit at Medak in Hyderabad.

1996 - The Company was planning to set up a new manufacturing unit
at
Masat (Silvassa) to meet the increasing demand for its
products.

- The Company undertook to set up jointly with Gujarat Agro
Industries Corporation a vegetable plant extraction project
for
the manufacture of glycirrhiza.

1997 - New products introduced were Gulbahar, Trishun Rub, Almalio
and
honey.

- 67,200 bonus shares issued in prop. 1:5.

- Credit Analysis & Research Ltd (CARE) has assigned a PRI+(PR
one plus) rating to the Commercial Paper programme of Zandu
Pharmaceutical Works Limited (Zandu) for Rs 60mn. This
rating
indicates superior capacity for repayment of short-term
promissory obligations.

- Zandu set up in 1910, manufactures about 300 ayurvedic drugs.
The major products are Zandu Balm, Chyavanprash Special and
Kesari Jivan.

1998 - The Rs 100-crore (Rs 100 crore = Rs 1 billion) company is one
of the leading players in the over-the-counter ayurvedic
healthcare segment with products including the popular Zandu
balm, general fitness medicine Zandu Kesari Jivan, Zandu
Chyavanprash and digestive tonic Zandu Pancharishta.

- The company launched new products such as Zandu Honey, and
Gulbahar, a medicated drink comparable to Hamdard's Rooh
Afza.
Zandu is also aiming at establishing a national presence.

- It has prescription products in the therapeutic segments of
arthritis, liver problems, and digestion.

1999 - The Mumbai-based Zandu Pharmaceutical Works is working on a
major
microbicides/spermicides project, which if successful, could
bring to the Indian market a preventive product for AIDS and
other sexually transmitted diseases. Zandu Pharmaceutical
Works
is renowned for popular brands like Zandu Balm, Zandu
Chyavanprash, Zandu Kesari Jivan, Alma Lio etc.

- The Indian company is also working on several new drugs
including those for the treatment of diabetes, diarrhoea and
plans were also afoot to move into the ayurvedic veterinary
segment, besides the cosmetics and toiletries segment.

- Zandu Pharma recently commissioned a consultancy to provide
inputs to streamline the organisation.

- The company has developed and introduced nature-based
over-the-counter (OTC) products and cosmetics.

- The company has set up finest research facilities where
extensive
reach is carried out in the field of Ayurvedic medicines with
the
help of modern testing techniques and latest production
facility.

- The company is also working on certain ayurvedic drugs for
the
cognitive functions of the brain and human trials would be
conducted in certain areas.

2000 - Dr. Krishnakant M Parikh, managing director of Zandu
Pharmaceutical Works, passed away on 4th August in Belgium.

2007

-The Company has issued Bonus Shares in the Ratio of 1:3.

2009

--Registered Office of the Company has been shifted to 687,
Anandapur, E.M. Bypass, Kolkata 700107 (West Bengal).

2010

-Company has changed its name from Zandu Pharmaceutical Works Ltd. to
Zandu Realty Ltd.

2011

-Zandu Realty has entered into a Development Agreement with M/s.
Sheth Corp Private Limited, Mumbai

2012

Nse Listed Companies with Live Charts